Restoring patient trust in healthcare: medical information impact case study in Poland.

Hospital Influence of information Medical profession Pandemic Payer Physicians

Journal

BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677

Informations de publication

Date de publication:
24 Aug 2021
Historique:
received: 17 12 2020
accepted: 03 08 2021
entrez: 25 8 2021
pubmed: 26 8 2021
medline: 27 8 2021
Statut: epublish

Résumé

This study empirically evaluates the influence of medical information on patient trust at the physician level, the medical profession, hospitals, and with the payer. Restoring patient trust in a medical setting in Poland appears to be significantly affected due to the COVID-19 pandemic. Patient trust improves results from medical treatment, raises perception of healthcare performance, and smoothens the overall functionality of healthcare systems. In order to study trust volatility, patients took part in a three-stage experiment designed via: (1) measured level of trust, (2) randomly dividing participants into two groups-control (i.e., re-examination of level of trust) and experimental (i.e., being exposed to a piece of certain manipulative information), and (3) checking whether observational changes were permanent. Results indicate that in the experimental group the increase of trust was noticed in the payer (27.7%, p < 0.001), hospitals (10.9%, p = 0.011), and physicians (decrease of 9.2%, p = 0.036). The study indicated that in Poland medical information is likely to influence patient trust in healthcare while interpersonal and social trust levels may be related to increases of trust in hospitals and in the payer versus decreases in physicians.

Sections du résumé

BACKGROUND BACKGROUND
This study empirically evaluates the influence of medical information on patient trust at the physician level, the medical profession, hospitals, and with the payer. Restoring patient trust in a medical setting in Poland appears to be significantly affected due to the COVID-19 pandemic. Patient trust improves results from medical treatment, raises perception of healthcare performance, and smoothens the overall functionality of healthcare systems.
METHODS METHODS
In order to study trust volatility, patients took part in a three-stage experiment designed via: (1) measured level of trust, (2) randomly dividing participants into two groups-control (i.e., re-examination of level of trust) and experimental (i.e., being exposed to a piece of certain manipulative information), and (3) checking whether observational changes were permanent.
RESULTS RESULTS
Results indicate that in the experimental group the increase of trust was noticed in the payer (27.7%, p < 0.001), hospitals (10.9%, p = 0.011), and physicians (decrease of 9.2%, p = 0.036).
CONCLUSION CONCLUSIONS
The study indicated that in Poland medical information is likely to influence patient trust in healthcare while interpersonal and social trust levels may be related to increases of trust in hospitals and in the payer versus decreases in physicians.

Identifiants

pubmed: 34429101
doi: 10.1186/s12913-021-06879-2
pii: 10.1186/s12913-021-06879-2
pmc: PMC8383260
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

865

Subventions

Organisme : european network for cost containment and improved quality of care
ID : COST Action CA15222
Organisme : narodowym centrum nauki
ID : 2015/17/B/HS4/02747

Informations de copyright

© 2021. The Author(s).

Références

Health Serv Res. 2002 Oct;37(5):1419-39
pubmed: 12479504
Med Decis Making. 2000 Apr-Jun;20(2):228-38
pubmed: 10772360
Med Decis Making. 2005 Jul-Aug;25(4):398-405
pubmed: 16061891
BMC Health Serv Res. 2013 Jan 16;13:22
pubmed: 23320786
Prog Pediatr Cardiol. 2020 Dec;59:101254
pubmed: 32837144
JAMA. 2020 May 19;323(19):1908-1909
pubmed: 32275299
Health Serv Res. 2002 Feb;37(1):187-202
pubmed: 11949920
J Acquir Immune Defic Syndr. 2001 Sep 1;28(1):47-58
pubmed: 11579277
Health Serv Res. 2004 Aug;39(4 Pt 1):813-23
pubmed: 15230929
Soc Sci Med. 2002 Mar;54(6):879-88
pubmed: 11996022
PLoS One. 2017 Feb 7;12(2):e0170988
pubmed: 28170443
Soc Sci Med. 2002 Jul;55(2):227-34
pubmed: 12144137
Health Commun. 2020 Apr;35(4):502-511
pubmed: 30706741
Health Expect. 2007 Dec;10(4):350-7
pubmed: 17986071
Soc Sci Med Med Psychol Med Sociol. 1979 Jan;13A(1):81-99
pubmed: 551529
Fam Pract. 2002 Oct;19(5):476-83
pubmed: 12356698
JAMA. 1996 Jun 5;275(21):1693-7
pubmed: 8637148
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
J Health Organ Manag. 2006;20(5):468-76
pubmed: 17087406
BMC Health Serv Res. 2005 Oct 03;5:64
pubmed: 16202125
J Gen Intern Med. 2003 Aug;18(8):617-23
pubmed: 12911643
Soc Sci Med. 2013 Aug;91:10-4
pubmed: 23849233
Hosp Pract (1995). 1999 Jul 15;34(7):69-72, 75-6, 79
pubmed: 10418553
Health Policy. 2019 Mar;123(3):281-287
pubmed: 30528656
Arthritis Rheum. 2003 Feb 15;49(1):51-8
pubmed: 12579593
J Gen Intern Med. 1998 Oct;13(10):681-6
pubmed: 9798815
BMJ Open. 2020 Jan 23;10(1):e028061
pubmed: 31980505
J Health Serv Res Policy. 2008 Oct;13 Suppl 3:97-103
pubmed: 18806199
J Gen Intern Med. 2000 Jul;15(7):509-13
pubmed: 10940139
J Am Geriatr Soc. 1993 Mar;41(3):223-8
pubmed: 8440842
Health Serv Res. 2005 Dec;40(6 Pt 1):1898-917
pubmed: 16336555
J Fam Pract. 1998 Sep;47(3):213-20
pubmed: 9752374
Lancet Infect Dis. 2020 Oct;20(10):e261-e267
pubmed: 32711692
Milbank Q. 2001;79(4):613-39, v
pubmed: 11789119
SAGE Open Med. 2016 Sep 01;4:2050312116664224
pubmed: 27635245
Milbank Q. 1996;74(2):171-89
pubmed: 8632733
Int J Health Plann Manage. 2020 Nov;35(6):1314-1334
pubmed: 32744754
Health Policy. 2019 Mar;123(3):288-292
pubmed: 30635139
AIDS Care. 2004 Jul;16(5):649-61
pubmed: 15223534
Soc Sci Med. 2016 Sep;165:75-81
pubmed: 27497858
Arch Intern Med. 2005 Aug 8-22;165(15):1749-55
pubmed: 16087823
BMC Public Health. 2006 Mar 02;6:52
pubmed: 16512907
Pharm World Sci. 2007 Apr;29(2):73-80
pubmed: 17187220
J Gen Intern Med. 2008 Jun;23(6):808-15
pubmed: 18415653
J Fam Pract. 2001 Apr;50(4):323-8
pubmed: 11300984
Appl Nurs Res. 2003 Nov;16(4):287-90
pubmed: 14608563
Health Aff (Millwood). 2004 Jul-Aug;23(4):124-32
pubmed: 15318572

Auteurs

Roman Lewandowski (R)

Faculty of Management, University of Social Sciences, Lodz, Poland.
Voivodeship Rehabilitation Hospital for Children in Ameryka, Ameryka, Poland.

Anatoliy G Goncharuk (AG)

Department of Management, International Humanitarian University, Odessa, Ukraine. agg@ua.fm.

Giuseppe T Cirella (GT)

Faculty of Economics, University of Gdansk, Sopot, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH